Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study.

Fonseca-Camarillo G, Furuzawa-Carballeda J, Granados J, Yamamoto-Furusho JK.

Clin Exp Immunol. 2014 Jul;177(1):64-75. doi: 10.1111/cei.12285.

2.

Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease.

Fonseca-Camarillo G, Furuzawa-Carballeda J, Yamamoto-Furusho JK.

Cytokine. 2015 Oct;75(2):389-402. doi: 10.1016/j.cyto.2015.04.009. Epub 2015 Jun 30.

PMID:
26141420
3.

Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.

Furuzawa-Carballeda J, Fonseca-Camarillo G, Lima G, Yamamoto-Furusho JK.

Clin Dev Immunol. 2013;2013:278035. doi: 10.1155/2013/278035. Epub 2013 Oct 27.

4.

Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.

Middel P, Reich K, Polzien F, Blaschke V, Hemmerlein B, Herms J, Korabiowska M, Radzun HJ.

Gut. 2001 Dec;49(6):795-803.

5.

Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.

Li J, Ueno A, Iacucci M, Fort Gasia M, Jijon HB, Panaccione R, Kaplan GG, Beck PL, Luider J, Barkema HW, Qian J, Gui X, Ghosh S.

Dig Dis Sci. 2017 Sep;62(9):2357-2368. doi: 10.1007/s10620-017-4596-9. Epub 2017 Jun 1.

PMID:
28573508
6.

Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.

Beltrán CJ, Candia E, Erranz B, Figueroa C, Gonzalez MJ, Quera R, Hermoso MA.

Eur Cytokine Netw. 2009 Mar;20(1):33-8. doi: 10.1684/ecn.2009.0142. Erratum in: Eur Cytokine Netw. 2009 Jun;20(2):94.

7.

Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.

Nielsen OH, Kirman I, Rüdiger N, Hendel J, Vainer B.

Scand J Gastroenterol. 2003 Feb;38(2):180-5.

PMID:
12678335
8.
9.

Interleukin 27 is up-regulated in patients with active inflammatory bowel disease.

Furuzawa Carballeda J, Fonseca Camarillo G, Yamamoto-Furusho JK.

Immunol Res. 2016 Aug;64(4):901-7. doi: 10.1007/s12026-016-8804-z.

PMID:
27221243
10.

Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis.

Hölttä V, Klemetti P, Salo HM, Koivusalo A, Pakarinen M, Westerholm-Ormio M, Kolho KL, Vaarala O.

J Pediatr Gastroenterol Nutr. 2013 Sep;57(3):287-92. doi: 10.1097/MPG.0b013e3182979252.

PMID:
23974060
11.

Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.

Schmidt C, Giese T, Ludwig B, Mueller-Molaian I, Marth T, Zeuzem S, Meuer SC, Stallmach A.

Inflamm Bowel Dis. 2005 Jan;11(1):16-23.

PMID:
15674109
13.

Expression of CD45RB functionally distinguishes intestinal T lymphocytes in inflammatory bowel disease.

Ten Hove T, The Olle F, Berkhout M, Bruggeman JP, Vyth-Dreese FA, Slors JF, Van Deventer SJ, Te Velde AA.

J Leukoc Biol. 2004 Jun;75(6):1010-5. Epub 2004 Mar 12.

PMID:
15020649
14.

Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.

Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Ghosh S.

Inflamm Bowel Dis. 2013 Nov;19(12):2522-34. doi: 10.1097/MIB.0b013e3182a85709.

PMID:
24097227
15.

Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.

D'Ambrosio A, Cossu A, Amendola A, Zandri A, Butera A, Sanchez M, Biffoni M, Pronio A, Montesani C, Kohn A, Pica R, Boirivant M.

J Crohns Colitis. 2016 Mar;10(3):346-53. doi: 10.1093/ecco-jcc/jjv216. Epub 2015 Nov 20.

16.

Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.

Koch Hansen L, Sevelsted-Møller L, Rabjerg M, Larsen D, Hansen TP, Klinge L, Wulff H, Knudsen T, Kjeldsen J, Köhler R.

J Crohns Colitis. 2014 Nov;8(11):1378-91. doi: 10.1016/j.crohns.2014.04.003. Epub 2014 May 3.

17.

An increased number of CD40-high monocytes in patients with Crohn's disease.

Sawada-Hase N, Kiyohara T, Miyagawa J, Ueyama H, Nishibayashi H, Murayama Y, Kashihara T, Nakahara M, Miyazaki Y, Kanayama S, Nezu R, Shinomura Y, Matsuzawa Y.

Am J Gastroenterol. 2000 Jun;95(6):1516-23.

PMID:
10894589
18.

Increased expression of interleukin 17 in inflammatory bowel disease.

Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y.

Gut. 2003 Jan;52(1):65-70.

19.

Interleukin-2 production in pediatric inflammatory bowel disease: evidence for dissimilar mononuclear cell function in Crohn's disease and ulcerative colitis.

Gurbindo C, Sabbah S, Menezes J, Justinich C, Marchand R, Seidman EG.

J Pediatr Gastroenterol Nutr. 1993 Oct;17(3):247-54.

PMID:
8271122
20.

Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.

Shih TC, Hsieh SY, Hsieh YY, Chen TC, Yeh CY, Lin CJ, Lin DY, Chiu CT.

World J Gastroenterol. 2008 Mar 21;14(11):1759-67.

Supplemental Content

Support Center